| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |